Korean beauty company behind the Medicube brand, selling skincare products and at-home beauty devices globally.
Korean beauty company behind the Medicube brand, selling skincare products and at-home beauty devices globally.
Sells largely through e-commerce and marketplaces, driving demand with heavy social-media and influencer marketing, so sales depend on brand buzz more than store shelves. Most sales now come from overseas rather than Korea. Devices carry higher prices than skincare, and the two are cross-sold.
In one line: Korea's e.l.f. Beauty crossed with a beauty-tech gadget maker..
Moat: narrow (brand, distribution). Fast-growing, socially viral Medicube brand with new US retail distribution (Ulta), but beauty trends can fade quickly.
Headquarters: Seoul, South Korea · Founded: 2014 · Employees: 657
Size APR (278470.KS) is a South Korea Consumer Staples company (Household/Personal Care) with a market value of $6.66B, the 61st largest of 483 South Korea companies the cockpit tracks. Shares closed at ₩235,000 on 18 Nov 2026.
Performance Over six months the shares fell 44.7%, against +15.1% for the median peer and -37.2% for the South Korea market (cap-weighted) — lowest of 21 in its peer set.
Growth Revenue grew 119.1% over the last twelve months (peer median +6.2%); the operating margin is 23.8% (peer median 13.8%).
Valuation It trades at 16.2× forward earnings against a peer median of 24.4× (6th cheapest of 20).
Price implies For today's price to make sense, revenue must grow about -2% a year for seven years (Req g). Recent delivered growth is +47%, so the hurdle is -50 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 54.8 points above its cost of capital (6.6% WACC).
Next results Next results expected around 15 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₩2.68T | ₩1.53T | ₩723B | ₩524B | ₩398B |
| Revenue growth | — | +111% | +38% | +32% | — |
| Gross profit | ₩2.05T | ₩1.14T | ₩524B | ₩382B | ₩281B |
| EBITDA | ₩676B | ₩396B | ₩145B | ₩118B | ₩50.0B |
| Net income | ₩468B | ₩290B | ₩108B | ₩81.5B | ₩29.0B |
| Free cash flow | ₩189B | ₩324B | ₩30.6B | ₩97.4B | ₩25.3B |
| Capital expenditure | ₩29.3B | ₩17.9B | ₩47.8B | ₩11.9B | ₩6.92B |
| Total debt | ₩228B | ₩101B | ₩109B | ₩22.2B | ₩34.5B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| APR 278470.KS | $6.66B | -45% | +119% | 24% | 16.2× | -2.3% |
| e.l.f. Beauty ELF | $6.73B | +124% | +40% | 14% | 34.3× | 24.1% |
| Amorepacific 090430.KS | $6.01B | 0% | +10% | 9% | 24.4× | 3.6% |
| LG H&h 051900.KS | $2.81B | -14% | -3% | 3% | 23.1× | -4.6% |
| L'Oreal OR.PA | $259B | +20% | +3% | 21% | 32.3× | 18.1% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 278470.KS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -24.2% | +8.6% | lowest of 21 |
| 6-month return | -44.7% | +15.1% | lowest of 21 |
| Distance from 52-week high | -50.5% | -7.9% | lowest of 21 |
| Revenue growth (TTM) | +119.1% | +6.2% | 2nd highest of 21 |
| Operating margin | 23.8% | 13.8% | 4th highest of 21 |
| Forward P/E | 16.2× | 24.4× | 6th cheapest of 20 |
| Growth the price implies (Req g, 7 yrs) | -2.3% | 4.1% | 5th least demanding of 20 |
| Growth delivered (Del g) | +47.3% | +5.4% | highest of 20 |
| Hurdle (Req g minus delivered) | -49.6 pp | -1.8 pp | least demanding of 20 |
| ROIC minus cost of capital | +54.8 pp | +4.2 pp | 2nd highest of 20 |
| EV / EBITDA | 13.2× | 14.5× | 9th cheapest of 19 |
| Net debt / EBITDA | 0.1× | -0.2× | 9th most indebted of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| APR 278470.KS | South Korea | $6.66B | -45% | +119% | 24% | 16.2× | -2.3% | +47.3% |
| e.l.f. Beauty ELF | United States | $6.73B | +124% | +40% | 14% | 34.3× | 24.1% | +38.8% |
| Dabur India DABUR.NS | India | $7.16B | -16% | +9% | 15% | 31.8× | 27.4% | +6.6% |
| Amorepacific 090430.KS | South Korea | $6.01B | 0% | +10% | 9% | 24.4× | 3.6% | -0.8% |
| Reynolds Consumer Products REYN | United States | $5.28B | +15% | +2% | 14% | 15.3× | 0.8% | +2.7% |
| Cupid CUPID.NS | India | $5.22B | +218% | +125% | 33% | n/a | n/a | n/a |
| Colgate-Palmolive (India) COLPAL.NS | India | $4.91B | -23% | +9% | 28% | 32.4× | 31.1% | +4.5% |
| Mao Geping Cosmetics 1318.HK | Hong Kong | $4.67B | -8% | +32% | 31% | 14.3× | 4.1% | +41.1% |
| Godrej Consumer Products GODREJCP.NS | India | $9.75B | -12% | +12% | 18% | 39.1× | 32.9% | +6.6% |
| Interparfums IPAR | United States | $4.28B | +48% | +3% | 18% | 28.4× | 10.5% | +22.5% |
| Shiseido 4911.T | Japan | $10.8B | +47% | +6% | 6% | 35.1× | 12.7% | +1.0% |
| Rohto Pharmaceutical 4527.T | Japan | $3.87B | +8% | +7% | 12% | 16.5× | -2.8% | +13.7% |
| Lion 4912.T | Japan | $3.85B | +44% | +6% | 8% | 24.3× | 0.9% | +3.5% |
| Coty COTY | United States | $3.71B | +116% | 0% | 5% | 13.5× | 9.8% | +4.6% |
| Puig Brands PUIG.MC | Spain | $12.4B | +31% | +4% | 16% | 18.1× | -2.6% | +11.7% |
| Marico MARICO.NS | India | $12.6B | +9% | +20% | 16% | 52.2× | 28.3% | +11.1% |
| Unicharm 8113.T | Japan | $13.0B | +20% | +2% | 11% | 26.9× | 0.1% | +5.4% |
| Clorox CLX | United States | $13.1B | +15% | +6% | 14% | 18.9× | 4.1% | -1.8% |
| Hengan Int'l 1044.HK | Hong Kong | $3.27B | -12% | +2% | 11% | 9.1× | -8.2% | -0.1% |
| Kobayashi Pharmaceutical 4967.T | Japan | $3.25B | +20% | +2% | 6% | 48.7× | 18.0% | +1.9% |
| Proya Cosmetics 603605.SS | China | $2.87B | -13% | +2% | 13% | 10.9× | -5.3% | +23.1% |